SGI
CPRX

Summit Global Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Summit Global Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$584K Sell
23,573
-3,369
-13% -$80.3K 0.03% 307
2025
Q4 		$629K Sell
26,942
-33,375
-55% -$743K 0.04% 270
2025
Q3 		$1.19M Buy
60,317
+3,902
+7% +$80.2K 0.07% 163
2025
Q2 		$1.22M Sell
56,415
-13,586
-19% -$321K 0.07% 153
2025
Q1 		$1.7M Sell
70,001
-3,880
-5% -$87.4K 0.12% 101
2024
Q4 		$1.54M Sell
73,881
-3,411
-4% -$73.3K 0.1% 154
2024
Q3 		$1.54M Buy
77,292
+1,923
+3% +$35.6K 0.1% 162
2024
Q2 		$1.17M Sell
75,369
-11,333
-13% -$176K 0.08% 213
2024
Q1 		$1.38M Sell
86,702
-3,810
-4% -$57.4K 0.1% 151
2023
Q4 		$1.52M Sell
90,512
-6,883
-7% -$94.1K 0.1% 158
2023
Q3 		$1.14M Buy
97,395
+72,890
+297% +$975K 0.08% 194
2023
Q2 		$329K Buy
+24,505
New +$353K 0.02% 404
2021
Q4 		– Sell
-130,000
Closed -$689K – 554
2021
Q3 		$689K Buy
130,000
+72,500
+126% +$396K 0.05% 258
2021
Q2 		$331K Buy
+57,500
New +$297K 0.02% 441

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Summit Global Investments's CPRX Position: Q1 2026 in Review

Summit Global Investments reduced its Catalyst Pharmaceutical (CPRX) stake by 13% in Q1 2026, selling an estimated $80.3K and leaving 23,573 shares worth $584K. The position accounts for 0.03% of the portfolio, ranked #307.

Summit Global Investments first reported a position in CPRX in Q2 2021 and has held it in 14 quarters since. The position peaked at $1.7M in Q1 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Summit Global Investments held 23,573 shares of Catalyst Pharmaceutical worth $584K as of Q1 2026.
  • Summit Global Investments sold 3,369 Catalyst Pharmaceutical shares in Q1 2026, an estimated $80.3K.
  • Catalyst Pharmaceutical made up 0.03% of Summit Global Investments's portfolio in Q1 2026, its #307 holding.
  • Summit Global Investments first reported a position in Catalyst Pharmaceutical in Q2 2021 and has held it in 14 quarters since.
  • Summit Global Investments's Catalyst Pharmaceutical position peaked at $1.7M in Q1 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.